Lifestyle
- Regular exercise
- Stress management
- Adequate sleep
Blutsenkungsgeschwindigkeit · ESR · Erythrozyten-Sedimentationsrate · Erythrocyte Sedimentation Rate
ESR quantifies the rate at which erythrocytes settle at the bottom of a test tube over one hour, reflecting the presence of inflammation.
Age Group
Reference ranges can vary based on age and sex; women and older adults may have higher normal ranges.
The erythrocyte sedimentation rate (ESR), also known as Blutsenkungsgeschwindigkeit (BSG) or Erythrozyten-Sedimentationsrate, is a blood test that measures the rate at which red blood cells sediment in a period of one hour. It is a non-specific marker of inflammation and is often used in conjunction with other tests, such as C-reactive protein (CRP), to assess inflammatory conditions. Clinically, ESR is significant in diagnosing and monitoring diseases characterized by systemic inflammation, such as rheumatoid arthritis, temporal arteritis, and systemic lupus erythematosus. Elevated ESR levels can indicate the presence of an inflammatory process, but they lack specificity and can be influenced by various factors. For athletes and biohackers, ESR may not directly correlate with performance or longevity but can provide insights into underlying inflammatory states that might affect recovery and overall health. However, ESR values can be confounded by factors such as age, sex, pregnancy, and anemia, and are not time-of-day sensitive. It is important to interpret ESR results in the context of a comprehensive clinical assessment.
Klinische Bedeutung
Elevated ESR values suggest the presence of inflammation, which may be due to infections, autoimmune diseases, or chronic inflammatory conditions. Low ESR values are generally not clinically significant but may occur in conditions like polycythemia or extreme leukocytosis.
Progressively rising ESR values suggest worsening inflammation or infection. Re-test in 4 weeks if outside optimal range.
Falling ESR values may indicate resolution of inflammation or effective treatment.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before starting any new supplementation, especially if you have underlying health conditions.
Testing Frequency
As needed for monitoring inflammatory conditions or as directed by a healthcare provider.
Correlated with
Current research suggests that the value of calprotectin as a biomarker for treatment response and flare after tapering in rheumatoid arthritis remains unclear, with no established reference ranges or optimal targets. Researchers have not yet established the specific confounders affecting calprotectin levels in various inflammatory conditions. Additionally, clinical questions remain unanswered regarding the long-term prognostic significance of calprotectin in disease progression and its comparative effectiveness against traditional markers like ESR and CRP.
475
Total Citations
10
Human/RCT
6.3
Avg. Influence
2025
Latest
Bray Christopher, et al. · WMJ : official publication of the State Medical Society of Wisconsin · 2016
This review examined the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) as markers of systemic inflammation. Researchers found that these tests should be interpreted alongside clinical history due to their lack of sensitivity and specificity. Discrepancies between ESR and CRP measurements were noted, particularly in chronic inflammatory diseases.
Key findings
Inciarte-Mundo José, et al. · Frontiers in immunology · 2022
Researchers found that calprotectin (S100A8/S100A9) levels are significantly elevated in rheumatoid arthritis (RA) patients and correlate better with disease activity than ESR or CRP. The study suggests that calprotectin may independently predict radiographic progression in RA. However, its role in assessing treatment response remains unclear.
Key findings
Researchers investigated the anti-inflammatory effects of remimazolam, an anesthetic agent, and found that it exhibited antioxidant properties. The study showed that patients receiving remimazolam had smaller increases in CRP levels post-surgery compared to those receiving dexmedetomidine. This suggests remimazolam may have beneficial effects on postoperative inflammation.
This systematic review assessed the frequency and clinical significance of elevated IgG4 in rheumatoid arthritis. Researchers found a significant correlation between IgG4 levels and disease activity, as well as with inflammatory markers like ESR and CRP. The study suggests that IgG4 may serve as a potential biomarker for disease activity.
This study reviewed the role of laboratory tests in diagnosing systemic vasculitis. Researchers found that while ESR and CRP are commonly used, they are nonspecific and do not differentiate between disease activity and other inflammatory sources.
This study explored the expression of lncRNA NEAT1 in spinal tuberculosis patients. Researchers found that NEAT1 levels were significantly elevated in patients and correlated with clinical characteristics and inflammatory markers like CRP and ESR. High NEAT1 expression was identified as an independent prognostic factor for patient outcomes.
This study focused on the standardization of methods for determining ESR. Researchers observed that modern approaches to automation and regular quality control are essential for improving the accuracy of ESR measurements in clinical practice.
This study identified clinical laboratory analytes as surrogate markers of subclinical inflammation in latent tuberculosis infection (LTBI). Researchers found that elevated ESR and platelet parameters were significantly associated with LTBI. The study suggests these markers could help predict the risk of progression from LTBI to active TB.
Cao Shixiong, et al. · International journal of rheumatic diseases · 2024
This study evaluated scavenger receptor-A (SRA) as a biomarker for disease activity in rheumatoid arthritis patients with normal ESR and CRP. Researchers observed that SRA levels correlated with disease activity indices and were more sensitive than ESR and CRP in identifying active disease. SRA may serve as a promising marker for assessing disease activity.
Key findings
Long Zhiwei, et al. · Frontiers in cellular and infection microbiology · 2024
Researchers found that invasive pulmonary aspergillosis (IPA) is increasingly common in patients with chronic obstructive pulmonary disease (COPD) and that current diagnostic methods are limited. They identified several blood markers that could improve early diagnosis of IPA, which is crucial for reducing mortality in these patients.
Key findings
Research publications about BSG over time
9totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer